Literature DB >> 28910979

CRISPR/Cas9-based efficient genome editing in Staphylococcus aureus.

Qi Liu1,2, Yu Jiang3,4, Lei Shao2, Ping Yang1,2, Bingbing Sun2,5, Sheng Yang3,4, Daijie Chen2,5.   

Abstract

Staphylococcus aureus is an important pathogenic bacterium prevalent in nosocomial infections and associated with high morbidity and mortality rates, which arise from the significant pathogenicity and multi-drug resistance. However, the typical genetic manipulation tools used to explore the relevant molecular mechanisms of S. aureus have multiple limitations: leaving a scar in the genome, comparatively low gene-editing efficiency, and prolonged experimental period. Here, we present a single-plasmid based on the clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated (Cas) system which allows rapid and efficient chromosomal manipulation in S. aureus. The plasmid carries the cas9 gene under the control of the constitutive promoter Pxyl/tet, a single guide RNA-encoding sequence transcribed via a strong promoter Pspac, and donor DNA used to repair the double strand breaks. The function of the CRISPR/Cas9 vector was demonstrated by deleting the tgt gene and the rocA gene, and by inserting the erm R cassette in S. aureus. This research establishes a CRISPR/Cas9 genome editing tool in S. aureus, which enables marker-free, scarless and rapid genetic manipulation, thus accelerating the study of gene function in S. aureus.
© The Author 2017. Published by Oxford University Press on behalf of the Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Staphylococci; gene; genotyping; molecular genetics; plasmid

Mesh:

Substances:

Year:  2017        PMID: 28910979     DOI: 10.1093/abbs/gmx074

Source DB:  PubMed          Journal:  Acta Biochim Biophys Sin (Shanghai)        ISSN: 1672-9145            Impact factor:   3.848


  10 in total

1.  Highly efficient base editing in Staphylococcus aureus using an engineered CRISPR RNA-guided cytidine deaminase.

Authors:  Tongnian Gu; Siqi Zhao; Yishuang Pi; Weizhong Chen; Chuanyuan Chen; Qian Liu; Min Li; Dali Han; Quanjiang Ji
Journal:  Chem Sci       Date:  2018-02-22       Impact factor: 9.825

2.  Efficient and Scalable Precision Genome Editing in Staphylococcus aureus through Conditional Recombineering and CRISPR/Cas9-Mediated Counterselection.

Authors:  Kelsi Penewit; Elizabeth A Holmes; Kathyrn McLean; Mingxin Ren; Adam Waalkes; Stephen J Salipante
Journal:  MBio       Date:  2018-02-20       Impact factor: 7.867

Review 3.  Phage Therapy: What Have We Learned?

Authors:  Andrzej Górski; Ryszard Międzybrodzki; Małgorzata Łobocka; Aleksandra Głowacka-Rutkowska; Agnieszka Bednarek; Jan Borysowski; Ewa Jończyk-Matysiak; Marzanna Łusiak-Szelachowska; Beata Weber-Dąbrowska; Natalia Bagińska; Sławomir Letkiewicz; Krystyna Dąbrowska; Jacques Scheres
Journal:  Viruses       Date:  2018-05-28       Impact factor: 5.048

4.  Editing the microbiome the CRISPR way.

Authors:  Gayetri Ramachandran; David Bikard
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-05-13       Impact factor: 6.237

Review 5.  Targeting Plasmids to Limit Acquisition and Transmission of Antimicrobial Resistance.

Authors:  Corneliu Ovidiu Vrancianu; Laura Ioana Popa; Coralia Bleotu; Mariana Carmen Chifiriuc
Journal:  Front Microbiol       Date:  2020-05-06       Impact factor: 5.640

6.  From cloning to mutant in 5 days: rapid allelic exchange in Staphylococcus aureus.

Authors:  Ian R Monk; Timothy P Stinear
Journal:  Access Microbiol       Date:  2021-01-07

Review 7.  Antibiotic Resistance Profiles, Molecular Mechanisms and Innovative Treatment Strategies of Acinetobacter baumannii.

Authors:  Corneliu Ovidiu Vrancianu; Irina Gheorghe; Ilda Barbu Czobor; Mariana Carmen Chifiriuc
Journal:  Microorganisms       Date:  2020-06-21

Review 8.  CRISPR base editing and prime editing: DSB and template-free editing systems for bacteria and plants.

Authors:  Zhengzheng Jiang; Xulin Hong; Shun Zhang; Ruilian Yao; Yi Xiao
Journal:  Synth Syst Biotechnol       Date:  2020-09-02

Review 9.  CRISPR-Cas, a Revolution in the Treatment and Study of ESKAPE Infections: Pre-Clinical Studies.

Authors:  Manuel González de Aledo; Mónica González-Bardanca; Lucía Blasco; Olga Pacios; Inés Bleriot; Laura Fernández-García; Melisa Fernández-Quejo; María López; Germán Bou; María Tomás
Journal:  Antibiotics (Basel)       Date:  2021-06-22

Review 10.  Emerging Strategies to Combat β-Lactamase Producing ESKAPE Pathogens.

Authors:  Corneliu Ovidiu Vrancianu; Irina Gheorghe; Elena-Georgiana Dobre; Ilda Czobor Barbu; Roxana Elena Cristian; Marcela Popa; Sang Hee Lee; Carmen Limban; Ilinca Margareta Vlad; Mariana Carmen Chifiriuc
Journal:  Int J Mol Sci       Date:  2020-11-12       Impact factor: 6.208

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.